>>> *VALEANT SAYS IT CAN'T JUSTIFY HOLDERS PAYING $219+ FOR ALLERGAN *VALEANT SAYS IT CAN'T JUSTIFY HOLDERS PAYING $219+ FOR ALLERGAN